![](https://endpts.com/wp-content/uploads/2023/04/Jason-Coloma-Maze-tile.jpg)
Jason Coloma, Maze CEO
After FTC scrutiny of Sanofi deal, Maze finds a new Pompe partner in Shionogi
Maze Therapeutics has found a new buyer for its Pompe disease candidate, five months after scrutiny from the Federal Trade Commission led Sanofi to back …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.